Biomarin Pharmaceutical Inc (BMRN)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 3,232,430 | 2,956,090 | 2,751,460 | 2,274,380 | 2,342,220 |
| Total current liabilities | US$ in thousands | 606,988 | 1,177,020 | 588,884 | 546,497 | 492,548 |
| Current ratio | 5.33 | 2.51 | 4.67 | 4.16 | 4.76 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $3,232,430K ÷ $606,988K
= 5.33
The current ratio of Biomarin Pharmaceutical Inc has shown fluctuations over the past five years, ranging from a high of 5.33 in December 31, 2024, to a low of 2.51 in December 31, 2023. The current ratio measures the company's ability to cover its short-term liabilities with its current assets.
A current ratio greater than 1 indicates that the company has more current assets than current liabilities, suggesting good liquidity. Biomarin Pharmaceutical Inc has consistently maintained a current ratio well above 1 over the years, indicating a strong ability to meet its short-term obligations.
However, the fluctuation in the current ratio over the years suggests some inconsistency in managing short-term assets and liabilities. Investors and analysts may want to further investigate the reasons behind these fluctuations to understand the company's liquidity position better. Overall, Biomarin Pharmaceutical Inc's current ratio indicates a generally healthy liquidity position, but close monitoring of short-term asset and liability management is recommended.
Peer comparison
Dec 31, 2024